The CIBER’s thematic area of Liver and Digestive Diseases (CIBEREHD) has the purpose of promoting and protecting health by furthering research. This work, whose scope includes both basic research and clinical and translational aspects, is based on the field of Liver and Digestive Diseases with the aim of innovating in the prevention of these diseases and promoting scientific and healthcare progress. At present the CIBEREHD has fifty groups (6 of these being linked) spread over nine of Spain’s Autonomous Communities, jointly working on four corporate programmes:
P1. Mechanisms of liver damage/evolution into advanced cirrhosis and transplant.
P2. Gastrointestinal physiopathology: inflammatory illness and motility disorders.
P3. Epidemiology, prevention and treatment of viral hepatitis infection.
P4. Liver and Digestive Oncology.
CIBER is a consortium dependent of the Institute de Salud Carlos III (Institute of Health Carlos III) through the Spain's Ministry of Science and Innovation and co-financed with ERDF and ESF funds. European Regional Development Fund (ERDF) “A way to make Europe”. European Social Fund (ESF) “The ESF invests in your future”.
